LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Sports Medicine/Apple Watch Band Records EKG
Sports Medicine

Apple Watch Band Records EKG

April 5, 2016 1 min read Premium comments

Advertisement

Apple Watch Band Records EKG
Courtesy of AliveCor
Secondary

A company called AliveCor, Inc. has produced a band for an Apple Watch that captures an EKG. The EKG is analyzed by a machine to detect trial fibrillation, a common cause of cardiac arrhythmia and a major cause of stroke. The firm is awaiting a 510(k) clearance from the FDA before launching the product commercially.

According to the company, a user can send a relevant EKG to his/her doctor, along with a voice memo regarding symptoms and any relevant external factors via the Apple Watch. Called the Kardia Band, the device integrates with the Apple Health app to have EKG data alongside information such as the number of steps taken and calorie intake.

AliveCor CEO Vic Gundotra told FierceMedicalDevices, “People have incredible amounts of data that they are carrying around on their wrist. Now, you can have our EKG device right on your wrist when you need it. We required a technical breakthrough to build it and make it this small.”

In addition to the band, AliveCor has rebranded its existing EKG device that attaches to the back of smartphones and tablets such as Kardia Mobile. Company officials report that the accompanying app has been upgraded to enable the patient to make a voice recording to describe symptoms and other relevant information that can accompany an EKG when it is sent to a physician.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy